INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/14/2026
Back to search
Official data from USPTO
ELVERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/14/2026
Trademark type
Word
Nice classes
5, 42
Filing date
12/21/2017
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
SE
Examiner
MAZZELLA, BRANDY BARRETT
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Swedish Orphan Biovitrum AB (publ)
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematologyinflammationgenetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematologyinflammationgenetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematologyinflammationgenetics and metabolism; modified chemical compounds for medical purposesfor the treatment of diseases and conditions in the therapeutic areas of hematologyinflammationgenetics and metabolism; modified protein arrays for medical use in the therapeutic areas of hematologyinflammationgenetics and metabolism; none of the aforementioned goods being cosmetic skin care preparations and cosmetics
Class 42
Research and development of pharmaceuticalsprotein pharmaceuticalsbiological pharmaceuticalsproteinsprotein structureschemical modification of substancescompounds for efficient effect of drugscompounds for controlled release of pharmaceutical substances within the pharmaceutical field; none of the aforementioned being cosmetic research
Publications
History of USPTO decisions and trademark events.
34 publications found
C71T
CANCELLED SECTION 71
11/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/30/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/16/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/20/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/20/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/16/2019
FIMP
FINAL DISPOSITION PROCESSED
08/15/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2019
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
01/03/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2018
RFNT
REFUSAL PROCESSED BY IB
04/27/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/09/2018
RFRR
REFUSAL PROCESSED BY MPU
04/09/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2018
CNRT
NON-FINAL ACTION WRITTEN
04/02/2018
DOCK
ASSIGNED TO EXAMINER
04/02/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2018
Continuous trademark protection
Get notified about every new filing that threatens ELVERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.